Export

EN
FR
Chloroquine
Essential medicine status
General description
Chloroquine is a medication used to prevent and to treat malaria in areas where malaria is known to be sensitive to its effects. It is also used as a disease-modifying agents in rheumatoid disorders.
Recommendations
Section
Antimalarial medicines > Medicines for curative treatment
  • Parenteral > General injections > IV: 40 mg per mL in 5 mL ampoule (as hydrochloride, phosphate or sulfate)
  • Oral > Liquid: 50 mg per 5 mL syrup (as phosphate or sulfate)
  • Oral > Solid: 150 mg tablet (as phosphate or sulfate); 100 mg tablet (as phosphate or sulfate)
  • Oral > Liquid: 50 mg per 5 mL (base)
  • Oral > Solid > tablet: 150 mg (base)
Section
Antimalarial medicines > Medicines for chemoprevention
  • Oral > Liquid: 50 mg per 5 mL syrup (as phosphate or sulfate)
  • Oral > Solid: 150 mg tablet (as phosphate or sulfate)
Section
Disease-modifying anti-rheumatic drugs (DMARDs)
  • Oral > Solid: 100 mg tablet (as phosphate or sulfate); 150 mg tablet (as phosphate or sulfate)
Section
Antimalarial medicines > Medicines for chemoprophylaxis in travellers
  • Oral > Liquid: 50 mg per 5 mL (base)
  • Oral > Solid > tablet: 150 mg (base)